Stem Cell Banking Market, by Source Type, Service Type, Application, and Region - Global Trends, and Forecast, 2022 - 2028
Stem cells have the potential to transform to any tissue or organ in the body. Stem cells can be found in bone marrow, fetal tissues, baby teeth, fat, human embryos, hair follicles, muscle, and circulating blood, however, cord blood is an effective source of stem cells. Stem cells from cord blood are preferred due to various advantages such as efficacy in transplant due to less chances of immune rejection during the transfusion. Numerous applications of stem cells such as treatment in various diseases such as cancer, have led to demand for stem cell banking. These stem cells are collected from humans and preserved for the future use.
Market Dynamics
Increasing incidences of chronic disease and the effectiveness of stem cell therapy in the treatment of such diseases is a major driving factor for growth of stem cell banking market. According to the survey by Seattle Children’s Hospital and Research Center, 2013, the survival rate of patient with cancer after stem cell transplant for period of one year was 84% globally. Growing public awareness for stem cell storage is also contributing to stem cell banking market growth. Additionally, new clinical trial data that supports applications for hematopoietic stem cells from mesenchymal stem cells and cord blood is expected to help in growth of stem cell banking market. Moreover, various organizations are supporting stem cell banking, which is expected to aid in growth of the market. For instance, in 2012, Harvard University and University of Cambridge announced plans to set up a new stem cells research center, funded by Medical Trust UK and UK Medical Research Council, to conduct research on stem cells and their potential to treat a range of life-threatening conditions. However, low availability of cord blood units, globally and high cost for maintenance are hindering growth of the stem cell banking market.
Key features of the study:
This report provides in-depth analysis of stem cell banking market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global stem cell banking market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, and strategies, and future plans
Key companies covered as a part of this study include Stem Cyte, Inc., Cryo-cell International, ViaCord, Cord Blood Registry, SmartCells, Inc., LifeCell International Pvt. Ltd., Cryoviva Biotech Pvt. Ltd., Cryo Stemcell, Reliance Life Sciences, and Transcell Biolife Pvt. Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
The global stem cell banking market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the stem cell banking market
Detailed Segmentation:
Global Stem Cell Banking Market, By Source Type:
Cord Blood
Cord Tissue
Global Stem Cell Banking Market, By Service Type:
Collection and Transportation
Processing
Analysis
Storage
Global Stem Cell Banking Market, By Application:
Leukemia
Diabetes
Lymphoma
Cerebral Palsy
Thalassemia
Others
Global Stem Cell Banking Market, By Geography:
North America
By Source Type:
Cord Blood
Cord Tissue
By Service Type:
Collection and Transportation
Processing
Analysis
Storage
By Application:
Leukemia
Diabetes
Lymphoma
Cerebral Palsy
Thalassemia
Others
By Country:
U.S.
Canada
Latin America
By Source Type:
Cord Blood
Cord Tissue
By Service Type:
Collection and Transportation
Processing
Analysis
Storage
By Application:
Leukemia
Diabetes
Lymphoma
Cerebral Palsy
Thalassemia
Others
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Source Type:
Cord Blood
Cord Tissue
By Service Type:
Collection and Transportation
Processing
Analysis
Storage
By Application:
Leukemia
Diabetes
Lymphoma
Cerebral Palsy
Thalassemia
Others
By Country:
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Source Type:
Cord Blood
Cord Tissue
By Service Type:
Collection and Transportation
Processing
Analysis
Storage
By Application:
Leukemia
Diabetes
Lymphoma
Cerebral Palsy
Thalassemia
Others
By Country:
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Source Type:
Cord Blood
Cord Tissue
By Service Type:
Collection and Transportation
Processing
Analysis
Storage
By Application:
Leukemia
Diabetes
Lymphoma
Cerebral Palsy
Thalassemia
Others
By Country:
GCC
Israel
Rest of Middle East
Africa
By Source Type:
Cord Blood
Cord Tissue
By Service Type:
Collection and Transportation
Processing
Analysis
Storage
By Application:
Leukemia
Diabetes
Lymphoma
Cerebral Palsy
Thalassemia
Others
By Country:
South Africa
Central Africa
North Africa
Company Profiles
Stem Cyte, Inc. *
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
Cryo-cell International
ViaCord
Cord Blood Registry
SmartCells, Inc.
LifeCell International Pvt. Ltd.
Cryoviva Biotech Pvt. Ltd.
Cryo Stemcell
Reliance Life Sciences
Transcell Biolife Pvt. Ltd.
“*” marked represents similar segmentation in other categories in the respective section.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook